Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 430

1.

Adult classical glioblastoma with a BRAF V600E mutation.

Takahashi Y, Akahane T, Sawada T, Ikeda H, Tempaku A, Yamauchi S, Nishihara H, Tanaka S, Nitta K, Ide W, Hashimoto I, Kamada H.

World J Surg Oncol. 2015 Mar 11;13(1):100.

PMID:
25885250
2.

Oncogenic osteomalacia caused by an occult paranasal sinus tumor.

Okamiya T, Takahashi K, Kamada H, Hirato J, Motoi T, Fukumoto S, Chikamatsu K.

Auris Nasus Larynx. 2015 Apr;42(2):167-9. doi: 10.1016/j.anl.2014.10.001. Epub 2015 Feb 11.

PMID:
25682388
3.

Evaluation of HNA-expressing cell line-based antigen capture systems and a solid-phase system for detecting HNA-1a antibodies.

Amakishi E, Irie Y, Nishizawa K, Kamada H, Nakajima F, Matsuyama N, Ishii H, Matsukura H, Yasui K, Hirayama F.

Int J Hematol. 2015 Apr;101(4):386-91. doi: 10.1007/s12185-015-1751-y. Epub 2015 Feb 3.

PMID:
25644150
4.

Factors influencing lymph node metastasis in patients with ampullary adenocarcinoma.

Okano K, Asano E, Kushida Y, Kamada H, Mori H, Suzuki Y.

Dig Surg. 2014;31(6):459-67. doi: 10.1159/000370251. Epub 2015 Jan 21.

PMID:
25613423
5.

Aminopeptidase P3, a new member of the TNF-TNFR2 signaling complex, induces phosphorylation of JNK1 and JNK2.

Inoue M, Kamada H, Abe Y, Higashisaka K, Nagano K, Mukai Y, Yoshioka Y, Tsutsumi Y, Tsunoda S.

J Cell Sci. 2015 Feb 15;128(4):656-69. doi: 10.1242/jcs.149385. Epub 2015 Jan 20.

PMID:
25609706
6.

Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer.

Sasaki T, Isayama H, Nakai Y, Ito Y, Yasuda I, Toda N, Yagioka H, Matsubara S, Hanada K, Maguchi H, Kamada H, Hasebe O, Mukai T, Okabe Y, Maetani I, Koike K.

World J Gastroenterol. 2014 Dec 28;20(48):18452-7. doi: 10.3748/wjg.v20.i48.18452.

7.

Generation and characterization of a bispecific diabody targeting both EPH receptor A10 and CD3.

Kamada H, Taki S, Nagano K, Inoue M, Ando D, Mukai Y, Higashisaka K, Yoshioka Y, Tsutsumi Y, Tsunoda S.

Biochem Biophys Res Commun. 2015 Jan 24;456(4):908-12. doi: 10.1016/j.bbrc.2014.12.030. Epub 2014 Dec 17.

PMID:
25528586
8.

Size and surface modification of amorphous silica particles determine their effects on the activity of human CYP3A4 in vitro.

Imai S, Yoshioka Y, Morishita Y, Yoshida T, Uji M, Nagano K, Mukai Y, Kamada H, Tsunoda S, Higashisaka K, Tsutsumi Y.

Nanoscale Res Lett. 2014 Dec 2;9(1):651. doi: 10.1186/1556-276X-9-651. eCollection 2014.

9.

Analysis of the amount of tissue sample necessary for mitotic count and Ki-67 index in gastrointestinal stromal tumor sampling.

Kobara H, Mori H, Rafiq K, Fujihara S, Nishiyama N, Chiyo T, Matsunaga T, Ayaki M, Yachida T, Kato K, Kamada H, Fujita K, Morishita A, Oryu M, Tsutsui K, Iwama H, Kushida Y, Haba R, Masaki T.

Oncol Rep. 2015 Jan;33(1):215-22. doi: 10.3892/or.2014.3608. Epub 2014 Nov 14.

PMID:
25405369
10.

Intestinal absorption and biological effects of orally administered amorphous silica particles.

Yoshida T, Yoshioka Y, Takahashi H, Misato K, Mori T, Hirai T, Nagano K, Abe Y, Mukai Y, Kamada H, Tsunoda S, Nabeshi H, Yoshikawa T, Higashisaka K, Tsutsumi Y.

Nanoscale Res Lett. 2014 Sep 26;9(1):532. doi: 10.1186/1556-276X-9-532. eCollection 2014.

11.

Usefulness of 11C-methionine positron emission tomography for detecting intracranial ameloblastic carcinoma: A case report.

Tempaku A, Takahashi Y, Ikeda H, Yamauchi S, Gotoh T, Bandoh N, Makino S, Shimada T, Kamada H.

Oncol Lett. 2014 Oct;8(4):1509-1512. Epub 2014 Jul 15.

12.

Clinical characteristics and pathogenesis of cerebellar glioblastoma.

Takahashi Y, Makino K, Nakamura H, Hide T, Yano S, Kamada H, Kuratsu J.

Mol Med Rep. 2014 Nov;10(5):2383-8. doi: 10.3892/mmr.2014.2549. Epub 2014 Sep 9.

PMID:
25199771
13.

Evaluation of gastric submucosal tumors using endoscopically visualized features with submucosal endoscopy.

Kobara H, Mori H, Rafiq K, Matsunaga T, Fujihara S, Nishiyama N, Ayaki M, Yachida T, Tani J, Miyoshi H, Kato K, Kamada H, Yoneyama H, Morishita A, Tsutsui K, Iwama H, Haba R, Masaki T.

Oncol Lett. 2014 Jul;8(1):161-168. Epub 2014 May 8.

14.

Ephrin receptor A10 is a promising drug target potentially useful for breast cancers including triple negative breast cancers.

Nagano K, Maeda Y, Kanasaki S, Watanabe T, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S.

J Control Release. 2014 Sep 10;189:72-9. doi: 10.1016/j.jconrel.2014.06.010. Epub 2014 Jun 16.

PMID:
24946238
15.

Correlation between positron emission tomography findings and glucose transporter 1, 3 and L-type amino acid transporter 1 mRNA expression in primary central nervous system lymphomas.

Takahashi Y, Akahane T, Yamamoto D, Nakamura H, Sawa H, Nitta K, Ide W, Hashimoto I, Kamada H.

Mol Clin Oncol. 2014 Jul;2(4):525-529. Epub 2014 May 5.

16.

Eph receptor A10 has a potential as a target for a prostate cancer therapy.

Nagano K, Yamashita T, Inoue M, Higashisaka K, Yoshioka Y, Abe Y, Mukai Y, Kamada H, Tsutsumi Y, Tsunoda S.

Biochem Biophys Res Commun. 2014 Jul 18;450(1):545-9. doi: 10.1016/j.bbrc.2014.06.007. Epub 2014 Jun 9.

PMID:
24924629
17.

Highly enantioselective synthesis of γ-, δ-, and ε-chiral 1-alkanols via Zr-catalyzed asymmetric carboalumination of alkenes (ZACA)-Cu- or Pd-catalyzed cross-coupling.

Xu S, Oda A, Kamada H, Negishi E.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8368-73. doi: 10.1073/pnas.1401187111. Epub 2014 May 27.

18.

Indications of endoscopic submucosal dissection for symptomatic benign gastrointestinal subepithelial or carcinoid tumors originating in the submucosa.

Kobara H, Mori H, Rafiq K, Fujihara S, Nishiyama N, Ayaki M, Yachida T, Tani J, Miyoshi H, Kamada H, Morishita A, Oryu M, Tsutsui K, Haba R, Masaki T.

Mol Clin Oncol. 2013 Nov;1(6):1002-1008. Epub 2013 Sep 6.

19.

Esophageal anthracosis with tuberculous lymphadenitis confirmed on transesophageal endoscopic ultrasound-guided fine-needle aspiration.

Nishiyama N, Mori H, Kobara H, Rafiq K, Fujihara S, Katou K, Aritomo Y, Ono M, Kamada H, Oryu M, Kanaji N, Masaki T.

Intern Med. 2014;53(6):577-80.

20.

Factors predicting survival and pathological subtype in patients with ampullary adenocarcinoma.

Okano K, Oshima M, Yachida S, Kushida Y, Kato K, Kamada H, Wato M, Nishihira T, Fukuda Y, Maeba T, Inoue H, Masaki T, Suzuki Y.

J Surg Oncol. 2014 Aug;110(2):156-62. doi: 10.1002/jso.23600. Epub 2014 Mar 12.

PMID:
24619853
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk